home / stock / sabsw / sabsw articles

SABSW Articles, SAB Biotherapeutics Inc. Warrant - From 11/14/23

Stock Information
Company Name: SAB Biotherapeutics Inc. Warrant
Stock Symbol: SABSW
Market: NASDAQ
Menu
SABSW SABSW Quote SABSW Short SABSW News SABSW Articles SABSW Message Board
Get SABSW Alerts

News, Short Squeeze, Breakout and More Instantly...
SAB Biotherapeutics Announces Q3 2023 Financial Results and Provides Company Updates | Benzinga

Raises combined $67.1M in private placement plus Tranche warrant exercise with syndicate of leading investors Received approval by the Human Resea...
SAB Biotherapeutics to Present at Piper Sandler Healthcare Conference | Benzinga

SIOUX FALLS, S.D., Nov. 09, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (NASDAQ:SABS), (SAB), a clinical-stage biopharmaceutical company ...

SAB Biotherapeutics Appoints Michael G. King Jr. as Chief Financial Officer | Benzinga

SIOUX FALLS, S.D., Oct. 24, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (NASDAQ:SABS), today announced that Michael G. King Jr. has been ...

SAB Biotherapeutics Approves Appointment of Andrew Moin to Board of Directors | Benzinga

SIOUX FALLS, S.D., Oct. 05, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ:SABS), a clinical-stage biopharmaceutical company with a nove...
SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes | Benzinga

Funding to support clinical advancement of SAB-142, a potential disease-modifying treatment Financing led by RA Capital Management, with participa...

Previous 10 Next 10